154 related articles for article (PubMed ID: 36682111)
21. Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with
Risør LM; Clausen MM; Ujmajuridze Z; Farhadi M; Andersen KF; Loft A; Friborg J; Kjaer A
J Nucl Med; 2022 Aug; 63(8):1169-1176. PubMed ID: 34857658
[TBL] [Abstract][Full Text] [Related]
22. A multi-objective radiomics model for the prediction of locoregional recurrence in head and neck squamous cell cancer.
Wang K; Zhou Z; Wang R; Chen L; Zhang Q; Sher D; Wang J
Med Phys; 2020 Oct; 47(10):5392-5400. PubMed ID: 32657426
[TBL] [Abstract][Full Text] [Related]
23. Prediction of 5-year progression-free survival in advanced nasopharyngeal carcinoma with pretreatment PET/CT using multi-modality deep learning-based radiomics.
Gu B; Meng M; Bi L; Kim J; Feng DD; Song S
Front Oncol; 2022; 12():899351. PubMed ID: 35965589
[TBL] [Abstract][Full Text] [Related]
24.
Sibille L; Seifert R; Avramovic N; Vehren T; Spottiswoode B; Zuehlsdorff S; Schäfers M
Radiology; 2020 Feb; 294(2):445-452. PubMed ID: 31821122
[TBL] [Abstract][Full Text] [Related]
25. Impact of (18)F-FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: A prospective observational study.
Ryu IS; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2016 Aug; 63():88-96. PubMed ID: 27288873
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of
Wang B; Liu J; Zhang X; Wang Z; Cao Z; Lu L; Lv W; Wang A; Li S; Wu X; Dong X
EJNMMI Res; 2023 Feb; 13(1):14. PubMed ID: 36779997
[TBL] [Abstract][Full Text] [Related]
27. Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysis.
Ceriani L; Milan L; Cascione L; Gritti G; Dalmasso F; Esposito F; Pirosa MC; Schär S; Bruno A; Dirnhofer S; Giovanella L; Hayoz S; Mamot C; Rambaldi A; Chauvie S; Zucca E
Hematol Oncol; 2022 Feb; 40(1):11-21. PubMed ID: 34714558
[TBL] [Abstract][Full Text] [Related]
28. Radiomics Analysis of PET and CT Components of PET/CT Imaging Integrated with Clinical Parameters: Application to Prognosis for Nasopharyngeal Carcinoma.
Lv W; Yuan Q; Wang Q; Ma J; Feng Q; Chen W; Rahmim A; Lu L
Mol Imaging Biol; 2019 Oct; 21(5):954-964. PubMed ID: 30671740
[TBL] [Abstract][Full Text] [Related]
29. Overall Survival Prognostic Modelling of Non-small Cell Lung Cancer Patients Using Positron Emission Tomography/Computed Tomography Harmonised Radiomics Features: The Quest for the Optimal Machine Learning Algorithm.
Amini M; Hajianfar G; Hadadi Avval A; Nazari M; Deevband MR; Oveisi M; Shiri I; Zaidi H
Clin Oncol (R Coll Radiol); 2022 Feb; 34(2):114-127. PubMed ID: 34872823
[TBL] [Abstract][Full Text] [Related]
30. A convolutional neural network-based system to classify patients using FDG PET/CT examinations.
Kawauchi K; Furuya S; Hirata K; Katoh C; Manabe O; Kobayashi K; Watanabe S; Shiga T
BMC Cancer; 2020 Mar; 20(1):227. PubMed ID: 32183748
[TBL] [Abstract][Full Text] [Related]
31. Deep Learning for Fully Automated Prediction of Overall Survival in Patients with Oropharyngeal Cancer Using FDG-PET Imaging.
Cheng NM; Yao J; Cai J; Ye X; Zhao S; Zhao K; Zhou W; Nogues I; Huo Y; Liao CT; Wang HM; Lin CY; Lee LY; Xiao J; Lu L; Zhang L; Yen TC
Clin Cancer Res; 2021 Jul; 27(14):3948-3959. PubMed ID: 33947697
[TBL] [Abstract][Full Text] [Related]
32. Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy.
Ye S; Han Y; Pan X; Niu K; Liao Y; Meng X
Front Oncol; 2022; 12():843991. PubMed ID: 35692757
[TBL] [Abstract][Full Text] [Related]
33. Attention Guided Lymph Node Malignancy Prediction in Head and Neck Cancer.
Chen L; Dohopolski M; Zhou Z; Wang K; Wang R; Sher D; Wang J
Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):1171-1179. PubMed ID: 33561508
[TBL] [Abstract][Full Text] [Related]
34. Radiomics features of the primary tumor fail to improve prediction of overall survival in large cohorts of CT- and PET-imaged head and neck cancer patients.
Ger RB; Zhou S; Elgohari B; Elhalawani H; Mackin DM; Meier JG; Nguyen CM; Anderson BM; Gay C; Ning J; Fuller CD; Li H; Howell RM; Layman RR; Mawlawi O; Stafford RJ; Aerts H; Court LE
PLoS One; 2019; 14(9):e0222509. PubMed ID: 31536526
[TBL] [Abstract][Full Text] [Related]
35. Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status.
Ou D; Blanchard P; Rosellini S; Levy A; Nguyen F; Leijenaar RTH; Garberis I; Gorphe P; Bidault F; Ferté C; Robert C; Casiraghi O; Scoazec JY; Lambin P; Temam S; Deutsch E; Tao Y
Oral Oncol; 2017 Aug; 71():150-155. PubMed ID: 28688683
[TBL] [Abstract][Full Text] [Related]
36. Improved Prognosis of Treatment Failure in Cervical Cancer with Nontumor PET/CT Radiomics.
Yusufaly TI; Zou J; Nelson TJ; Williamson CW; Simon A; Singhal M; Liu H; Wong H; Saenz CC; Mayadev J; McHale MT; Yashar CM; Eskander R; Sharabi A; Hoh CK; Obrzut S; Mell LK
J Nucl Med; 2022 Jul; 63(7):1087-1093. PubMed ID: 34711618
[TBL] [Abstract][Full Text] [Related]
37. Radiomics Analysis of PET and CT Components of
Wang X; Lu Z
Front Oncol; 2021; 11():638124. PubMed ID: 33928029
[TBL] [Abstract][Full Text] [Related]
38. The importance of feature aggregation in radiomics: a head and neck cancer study.
Fontaine P; Acosta O; Castelli J; De Crevoisier R; Müller H; Depeursinge A
Sci Rep; 2020 Nov; 10(1):19679. PubMed ID: 33184313
[TBL] [Abstract][Full Text] [Related]
39. Dosimetric evaluation of synthetic CT for head and neck radiotherapy generated by a patch-based three-dimensional convolutional neural network.
Dinkla AM; Florkow MC; Maspero M; Savenije MHF; Zijlstra F; Doornaert PAH; van Stralen M; Philippens MEP; van den Berg CAT; Seevinck PR
Med Phys; 2019 Sep; 46(9):4095-4104. PubMed ID: 31206701
[TBL] [Abstract][Full Text] [Related]
40. The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status.
Moan JM; Amdal CD; Malinen E; Svestad JG; Bogsrud TV; Dale E
Radiother Oncol; 2019 Nov; 140():54-61. PubMed ID: 31177043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
